MicroRNAs: Turning the Tide in Testicular Cancer

Nirmish Singla, John T. Lafin, Aditya Bagrodia

Research output: Contribution to journalEditorialpeer-review

7 Scopus citations


MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.

Original languageEnglish (US)
Pages (from-to)541-542
Number of pages2
JournalEuropean urology
Issue number5
StatePublished - Nov 2019

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'MicroRNAs: Turning the Tide in Testicular Cancer'. Together they form a unique fingerprint.

Cite this